Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.

Shin S, Kim TH, Jeong SW, Chung SE, Lee DY, Kim DH, Shin BS.

PLoS One. 2019 May 15;14(5):e0216875. doi: 10.1371/journal.pone.0216875. eCollection 2019.

2.

Small gold nanorods-loaded hybrid albumin nanoparticles with high photothermal efficacy for tumor ablation.

Seo B, Lim K, Kim SS, Oh KT, Lee ES, Choi HG, Shin BS, Youn YS.

Colloids Surf B Biointerfaces. 2019 Apr 1;179:340-351. doi: 10.1016/j.colsurfb.2019.03.068. [Epub ahead of print]

PMID:
30991214
3.

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban.

Kim M, Son H, Noh K, Kim E, Shin BS, Kang W.

Pharmaceutics. 2019 Mar 19;11(3). pii: E133. doi: 10.3390/pharmaceutics11030133.

4.

Stereo-Selective Pharmacokinetics of Ilimaquinone Epimers Extracted from a Marine Sponge in Rats.

Son H, Noh K, Park I, Na M, Oh S, Shin BS, Kang W.

Mar Drugs. 2019 Mar 17;17(3). pii: E171. doi: 10.3390/md17030171.

5.

Real-time monitoring of water quality of stream water using sulfur-oxidizing bacteria as bio-indicator.

Hassan SHA, Gurung A, Kang WC, Shin BS, Rahimnejad M, Jeon BH, Kim JR, Oh SE.

Chemosphere. 2019 May;223:58-63. doi: 10.1016/j.chemosphere.2019.01.089. Epub 2019 Jan 31.

PMID:
30769290
6.

Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-inhibiting Phthalimido-Alkanamide Derivative.

Wee CW, Kim JH, Kim HJ, Kang HC, Suh SY, Shin BS, Ma E, Kim IH.

Anticancer Res. 2019 Feb;39(2):759-769. doi: 10.21873/anticanres.13173.

PMID:
30711955
7.

Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens.

Lee KW, Kim TH, Lee JB, Kim KS, Park JB, Gershkovich P, Yoo SD, Shin S, Shin BS, Kim SJ.

J Pharmacol Sci. 2019 Feb;139(2):65-71. doi: 10.1016/j.jphs.2018.05.013. Epub 2018 Dec 11.

8.

Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.

Kim TH, Bulitta JB, Kim DH, Shin S, Shin BS.

Int J Pharm. 2019 Feb 10;556:276-286. doi: 10.1016/j.ijpharm.2018.12.007. Epub 2018 Dec 11.

PMID:
30543888
9.

Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry.

Shin S, Jeong HM, Chung SE, Kim TH, Thapa SK, Lee DY, Song CH, Lim JY, Cho SM, Nam KY, Kang WH, Choi YW, Shin BS.

J Pharm Biomed Anal. 2019 Feb 20;165:101-111. doi: 10.1016/j.jpba.2018.11.051. Epub 2018 Nov 24.

PMID:
30522064
10.

Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats.

Kim TH, Paik SH, Chi YH, Bulitta JB, Lee DY, Lim JY, Chung SE, Song CH, Jeong HM, Shin S, Shin BS.

Pharmaceutics. 2018 Oct 3;10(4). pii: E174. doi: 10.3390/pharmaceutics10040174.

11.

Quantitative Prediction of Oral Bioavailability of a Lipophilic Antineoplastic Drug Bexarotene Administered in Lipidic Formulation Using a Combined In Vitro Lipolysis/Microsomal Metabolism Approach.

Lee JB, Kim TH, Feng W, Choi HG, Zgair A, Shin S, Yoo SD, Gershkovich P, Shin BS.

J Pharm Sci. 2019 Feb;108(2):1047-1052. doi: 10.1016/j.xphs.2018.09.025. Epub 2018 Sep 28.

PMID:
30268807
12.

Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats.

Kim TH, Thapa SK, Lee DY, Chung SE, Lim JY, Jeong HM, Song CH, Choi YW, Cho SM, Nam KY, Kang WH, Shin S, Shin BS.

Pharmaceutics. 2018 Sep 6;10(3). pii: E152. doi: 10.3390/pharmaceutics10030152.

13.

Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.

Phuong PTT, Lee S, Lee C, Seo B, Park S, Oh KT, Lee ES, Choi HG, Shin BS, Youn YS.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:123-133. doi: 10.1016/j.colsurfb.2018.07.016. Epub 2018 Jul 10.

PMID:
30025374
14.

Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.

Lee JB, Zgair A, Malec J, Kim TH, Kim MG, Ali J, Qin C, Feng W, Chiang M, Gao X, Voronin G, Garces AE, Lau CL, Chan TH, Hume A, McIntosh TM, Soukarieh F, Al-Hayali M, Cipolla E, Collins HM, Heery DM, Shin BS, Yoo SD, Kagan L, Stocks MJ, Bradshaw TD, Fischer PM, Gershkovich P.

J Control Release. 2018 Sep 28;286:10-19. doi: 10.1016/j.jconrel.2018.07.022. Epub 2018 Jul 18.

15.

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.

Bulitta JB, Jiao Y, Drescher SK, Oliver A, Louie A, Moya B, Tao X, Wittau M, Tsuji BT, Zavascki AP, Shin BS, Drusano GL, Sörgel F, Landersdorfer CB.

Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x. Review.

PMID:
29936678
16.

Tissue distribution of gold and silver after subacute intravenous injection of co-administered gold and silver nanoparticles of similar sizes.

Lee JH, Sung JH, Ryu HR, Song KS, Song NW, Park HM, Shin BS, Ahn K, Gulumian M, Faustman EM, Yu IJ.

Arch Toxicol. 2018 Apr;92(4):1393-1405. doi: 10.1007/s00204-018-2173-4. Epub 2018 Feb 15.

PMID:
29450565
17.

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.

Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02055-17. doi: 10.1128/AAC.02055-17. Print 2018 Apr.

18.

Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice.

Kim TH, Shin S, Yoo SD, Shin BS.

Molecules. 2018 Feb 7;23(2). pii: E349. doi: 10.3390/molecules23020349.

19.

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.

Landersdorfer CB, Yadav R, Rogers KE, Kim TH, Shin BS, Boyce JD, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02053-17. doi: 10.1128/AAC.02053-17. Print 2018 Apr.

20.

Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in Rats.

Weon KY, Kim MG, Shin S, Kim TH, Joo SH, Ma E, Jeong SW, Yoo SD, Youn YS, Shin BS.

Chin J Integr Med. 2018 Jun;24(6):460-466. doi: 10.1007/s11655-017-2907-9. Epub 2018 Jan 15.

PMID:
29335861

Supplemental Content

Loading ...
Support Center